<p>New Delhi: Shares of Sun Pharmaceutical Industries on Friday tumbled nearly 6 per cent after the company reported a 20 per cent year-on-year decline in consolidated net profit for the first quarter ended June 30, 2025.</p>.<p>Extending its previous day's decline, the company's stock tanked 5.70 per cent to Rs 1,608.30 on the BSE.</p>.<p>At the NSE, it dropped 5.78 per cent to Rs 1,608.</p>.<p>Shares of Sun Pharmaceutical Industries had on Thursday fell by nearly 2 per cent.</p>.Sun Pharma launches anti-baldness drug Leqselvi in US.<p>Sun Pharmaceutical Industries on Thursday reported a 20 per cent year-on-year decline in consolidated net profit to Rs 2,279 crore for the first quarter ended June 30, 2025.</p>.<p>The Mumbai-based drug major posted a net profit of Rs 2,836 crore for the April-June quarter of the last financial year.</p>.<p>Adjusted net profit, excluding the exceptional items, for the first quarter stood at Rs 2,996 crore, up 6 per cent year-on-year.</p>.<p>Total income rose to 14,316 crore for the June quarter against Rs 13,185 crore in the year-ago period, Sun Pharma said in a regulatory filing.</p>
<p>New Delhi: Shares of Sun Pharmaceutical Industries on Friday tumbled nearly 6 per cent after the company reported a 20 per cent year-on-year decline in consolidated net profit for the first quarter ended June 30, 2025.</p>.<p>Extending its previous day's decline, the company's stock tanked 5.70 per cent to Rs 1,608.30 on the BSE.</p>.<p>At the NSE, it dropped 5.78 per cent to Rs 1,608.</p>.<p>Shares of Sun Pharmaceutical Industries had on Thursday fell by nearly 2 per cent.</p>.Sun Pharma launches anti-baldness drug Leqselvi in US.<p>Sun Pharmaceutical Industries on Thursday reported a 20 per cent year-on-year decline in consolidated net profit to Rs 2,279 crore for the first quarter ended June 30, 2025.</p>.<p>The Mumbai-based drug major posted a net profit of Rs 2,836 crore for the April-June quarter of the last financial year.</p>.<p>Adjusted net profit, excluding the exceptional items, for the first quarter stood at Rs 2,996 crore, up 6 per cent year-on-year.</p>.<p>Total income rose to 14,316 crore for the June quarter against Rs 13,185 crore in the year-ago period, Sun Pharma said in a regulatory filing.</p>